Alvarado CI, Picón CG, García ÁKG, Valencia CR, Barroso BS

Language: Spanish
References: 12
Page: 18-22
PDF size: 150.86 Kb.

ABSTRACT

Background: Metastatic breast cancer (MBC) patients have long been considered “forgotten heroines” because studies looking for new therapeutic options give little attention to them. Breast cancer-distance metastases are known to have a poor prognosis and are more common than loco-regional or contra lateral relapses.
Objectives: To determine if there is any relation between metastatic patterns of breast cancer and histological degree of primary tumor, hormonal profile, p53 expression and size. To assess the diferences of metastatic patterns between infiltrating ductal carcinoma and infiltrating lobulillar carcinoma, as well as hormonal receptor expression between primary and metastatic tumors.
Patients and methods: Clinical and pathological characteristics were analized, as well as hormonal profiles of 300 patients with metastatic breast cancer treated at Oncology Hospital, National Medical Center Siglo XXI, IMSS, Mexico.
Results: There was a significant correlation was also demonstrated between histological low degree tumors and higher frequency of lung or liver metastases. a significant correlation was also demonstrated between histological low degree tumors and higher frequency of bone metastases. Overall survival of patients with bone metastases was higher than that of women with lung metastases (p 0.020). Patients with metastatic tumors positive to estrogen and progesterone receptors had a longer survival than women with tumors positive to one of the receptors; patients with both markers negative had the poorest prognosis.
Conclusion: There is a correlation between breast cancer dissemination patterns and histological degree; it is important to analyze in metastatic breast cancer hormonal markers because they have predictive and prognostic value.

REFERENCES

1. Cardoso F. Metastatic breast cancer patients: the forgotten heroes. The Breast 2009;18:271-272.

2. Kamby C, Rose C, Iverson H. Patterns of metastases in human breast carcinoma en relation to estrogen receptor status. Anticancer Res 1986;6:107-112.

3. Ellis IO, Galea M, Broughton N. Pathological prognostic factors in breast cancer. Histological type-relationship with survival in a large study with long-term-follow-up. Histopathology 1991;19:403-410.

4. Porter GJR, Evans AJ, Pinder SE. Patterns of metastatic Radiology 2004;59:1094-1098.

5. Blanco G, Holff K, Heikkin M. Prognostic factors in recurrent breast cancer: relationship to site of recurrence, disease free interval, female sex steroid receptors, ploidy and histologic malignant grading. Br J Cancer 1990;62:142-146.

6. Zheng W, Lu J, Zheng J, et al. Variation of ER status between primary and metastatic breast cancer and relationship to p53 expresion. Steroids 2001;66:905-910.

7. noma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:149-156.

8. Bane AL, Tyon S, Parkes RK, et al. Invasive lobular carcinoma: To grade or not to grade. Modern Pathology 2005;18:621- 628.

9. Stuart Harris R, Shadbolt B, Palmqvist C, et al.The prognostic breast cancer: An analysis of three randomized phase III trials of aromatase inhibitors. Breast 2009;1:1-5.

10. Rugo HS. The importance of distant metastases in hormonesensitive breast cancer. Breast 2008;17(51):53-58.

11. Marchiò C, Reis-Filho JS. Molecular diagnosis in breast cancer. Diagnostic histopathology 2008;14(5):202-213.

12. Sotiriou CH, Pusztai L. Gene expression signatures in breast cancer. N Engl J Med 2009;360:790-800.